Impact of Myc in HIV-associated non-Hodgkin lymphomas treated with EPOCH and outcomes with vorinostat (AMC-075 trial)

EPOCH (etoposide, prednisone, vincristine, cyclophosphamide, and doxorubicin) is a preferred regimen for HIV-non-Hodgkin lymphomas (HIV-NHLs), which are frequently Epstein-Barr virus (EBV) positive or human herpesvirus type-8 (HHV-8) positive. The histone deacetylase (HDAC) inhibitor vorinostat disr...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Blood
Autors principals: Ramos, Juan C., Sparano, Joseph A., Chadburn, Amy, Reid, Erin G., Ambinder, Richard F., Siegel, Eric R., Moore, Page C., Rubinstein, Paul G., Durand, Christine M., Cesarman, Ethel, Aboulafia, David, Baiocchi, Robert, Ratner, Lee, Kaplan, Lawrence, Capoferri, Adam A., Lee, Jeannette Y., Mitsuyasu, Ronald, Noy, Ariela
Format: Artigo
Idioma:Inglês
Publicat: American Society of Hematology 2020
Matèries:
Clinical Trials and Observations
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC7483436/
https://ncbi.nlm.nih.gov/pubmed/32430507
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1182/blood.2019003959
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars